Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-04-002020
Filing Date
2004-03-30
Accepted
2004-03-30 17:20:49
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d58789_10k.htm 10-K 1501241
3 PARTNERSHIP AGREEMENT d58789_ex10-51.htm EX-10.51 305134
4 GRAPHIC logo.jpg GRAPHIC 4796
5 SUBSIDIARIES OF THE REGISTRANT d58789_ex21-1.htm EX-21.1 1560
6 CONSENTS OF EXPERTS AND COUNSEL d58789_ex23-1.htm EX-23.1 2777
7 CERTIFICATIONS REQUIRED UNDER SECTION 302 d58789_ex31-1.htm EX-31.1 7651
8 CERTIFICATIONS REQUIRED UNDER SECTION 302 d58789_ex31-2.htm EX-31.2 7709
9 CERTIFICATIONS REQUIRED UNDER SECTION 906 d58789_ex32-1.htm EX-32.1 6514
  Complete submission text file 0001169232-04-002020.txt   1839814
Mailing Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005
Business Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005 6506241000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26483 | Film No.: 04702593
SIC: 2834 Pharmaceutical Preparations